Literature DB >> 15708565

Effects of canonical Wnt signaling on dorso-ventral specification of the mouse telencephalon.

Mattias Backman1, Ondrej Machon, Line Mygland, Christiaan Johannes van den Bout, Weimin Zhong, Makoto M Taketo, Stefan Krauss.   

Abstract

Wnt signaling is involved in numerous processes during vertebrate CNS development. In this study, we used conditional Cre/loxP system in mouse to ablate or activate beta-catenin in the telencephalon in two time windows: before and after the onset of neurogenesis. We show that beta-catenin mediated Wnt signals are required to maintain the molecular identity of the pallium. Inactivation of beta-catenin in the telencephalon before neurogenesis results in downregulated expression of dorsal markers Emx1, Emx2 and Ngn2, and in ectopic up-regulation of ventral markers Gsh2, Mash1 and Dlx2 in the pallium. In contrast, ablation of ss-catenin after the onset of cortical neurogenesis (E11.5) does not result in a dorso-ventral fate shift. In addition, activation of canonical Wnt signaling in the subpallium leads to a repression of ventral telencephalic cell identities as shown by the down-regulation of subpallial markers Dlx2, Nkx2.1, Gsh2, Olig2 and Mash1. This was accompanied with an expansion of dorsal identities ventrally as shown by the expanded expression domains of pallial markers Pax6 and Ngn2. Thus, our data suggest that canonical Wnt signals are involved in maintaining the identity of the pallium by controlling expression of dorsal markers and by suppressing ventral programs from being activated in pallial progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708565     DOI: 10.1016/j.ydbio.2004.12.010

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  81 in total

1.  Wnts influence the timing and efficiency of oligodendrocyte precursor cell generation in the telencephalon.

Authors:  Abraham J Langseth; Roeben N Munji; Youngshik Choe; Trung Huynh; Christine D Pozniak; Samuel J Pleasure
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

2.  Wnt signaling and forebrain development.

Authors:  Susan J Harrison-Uy; Samuel J Pleasure
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

3.  Linking cell signaling and the epigenetic machinery.

Authors:  Helai P Mohammad; Stephen B Baylin
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

4.  Lewis X-carrying N-glycans regulate the proliferation of mouse embryonic neural stem cells via the Notch signaling pathway.

Authors:  Hirokazu Yagi; Takuya Saito; Makoto Yanagisawa; Robert K Yu; Koichi Kato
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

Review 5.  iPSC-based drug screening for Huntington's disease.

Authors:  Ningzhe Zhang; Barbara J Bailus; Karen L Ring; Lisa M Ellerby
Journal:  Brain Res       Date:  2015-09-30       Impact factor: 3.252

6.  Genomic DISC1 Disruption in hiPSCs Alters Wnt Signaling and Neural Cell Fate.

Authors:  Priya Srikanth; Karam Han; Dana G Callahan; Eugenia Makovkina; Christina R Muratore; Matthew A Lalli; Honglin Zhou; Justin D Boyd; Kenneth S Kosik; Dennis J Selkoe; Tracy L Young-Pearse
Journal:  Cell Rep       Date:  2015-08-20       Impact factor: 9.423

Review 7.  Radial glia in the ventral telencephalon.

Authors:  Miguel Turrero García; Corey C Harwell
Journal:  FEBS Lett       Date:  2017-09-19       Impact factor: 4.124

Review 8.  The genetics of early telencephalon patterning: some assembly required.

Authors:  Jean M Hébert; Gord Fishell
Journal:  Nat Rev Neurosci       Date:  2008-09       Impact factor: 34.870

9.  Beta-catenin-mediated Wnt signaling regulates neurogenesis in the ventral telencephalon.

Authors:  Alexandra A Gulacsi; Stewart A Anderson
Journal:  Nat Neurosci       Date:  2008-11-09       Impact factor: 24.884

Review 10.  Modeling Huntington's disease with induced pluripotent stem cells.

Authors:  Julia A Kaye; Steven Finkbeiner
Journal:  Mol Cell Neurosci       Date:  2013-02-28       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.